A detailed history of Hartford Investment Management CO transactions in Johnson & Johnson stock. As of the latest transaction made, Hartford Investment Management CO holds 151,324 shares of JNJ stock, worth $23.5 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
151,324
Previous 154,022 1.75%
Holding current value
$23.5 Million
Previous $22.5 Million 8.94%
% of portfolio
0.82%
Previous 0.78%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$145.48 - $167.38 $392,505 - $451,591
-2,698 Reduced 1.75%
151,324 $24.5 Million
Q2 2024

Aug 01, 2024

SELL
$144.38 - $157.78 $211,805 - $231,463
-1,467 Reduced 0.94%
154,022 $22.5 Million
Q1 2024

Apr 17, 2024

SELL
$155.22 - $162.74 $1.03 Million - $1.08 Million
-6,666 Reduced 4.11%
155,489 $24.6 Million
Q4 2023

Jan 23, 2024

SELL
$145.6 - $158.88 $374,920 - $409,116
-2,575 Reduced 1.56%
162,155 $25.4 Million
Q3 2023

Oct 16, 2023

SELL
$155.75 - $174.48 $2.83 Million - $3.17 Million
-18,180 Reduced 9.94%
164,730 $25.7 Million
Q2 2023

Jul 19, 2023

SELL
$154.35 - $166.11 $5.77 Million - $6.21 Million
-37,375 Reduced 16.97%
182,910 $30.3 Million
Q1 2023

May 09, 2023

BUY
$151.05 - $180.26 $4.71 Million - $5.62 Million
31,166 Added 16.48%
220,285 $34.1 Million
Q4 2022

Jan 20, 2023

SELL
$160.2 - $179.79 $9.7 Million - $10.9 Million
-60,563 Reduced 24.26%
189,119 $33.4 Million
Q3 2022

Nov 02, 2022

SELL
$161.33 - $179.52 $394,129 - $438,567
-2,443 Reduced 0.97%
249,682 $40.8 Million
Q2 2022

Jul 22, 2022

BUY
$168.19 - $186.01 $529,798 - $585,931
3,150 Added 1.27%
252,125 $44.8 Million
Q1 2022

Apr 20, 2022

SELL
$158.14 - $179.59 $2.91 Million - $3.31 Million
-18,406 Reduced 6.88%
248,975 $44.1 Million
Q4 2021

Feb 02, 2022

BUY
$155.93 - $173.01 $1.25 Million - $1.38 Million
7,994 Added 3.08%
267,381 $45.7 Million
Q3 2021

Nov 01, 2021

SELL
$161.5 - $179.47 $5.09 Million - $5.66 Million
-31,519 Reduced 10.83%
259,387 $41.9 Million
Q2 2021

Jul 29, 2021

SELL
$159.48 - $171.07 $1.03 Million - $1.1 Million
-6,447 Reduced 2.17%
290,906 $47.9 Million
Q1 2021

Apr 21, 2021

SELL
$153.07 - $170.48 $1.62 Million - $1.8 Million
-10,566 Reduced 3.43%
297,353 $48.9 Million
Q4 2020

Feb 01, 2021

BUY
$137.11 - $157.38 $4.18 Million - $4.8 Million
30,482 Added 10.99%
307,919 $48.5 Million
Q3 2020

Oct 29, 2020

SELL
$140.38 - $153.83 $1.5 Million - $1.64 Million
-10,658 Reduced 3.7%
277,437 $41.3 Million
Q2 2020

Aug 04, 2020

SELL
$128.81 - $155.51 $9.85 Million - $11.9 Million
-76,497 Reduced 20.98%
288,095 $40.5 Million
Q1 2020

Apr 24, 2020

SELL
$111.14 - $153.99 $1.27 Million - $1.76 Million
-11,430 Reduced 3.04%
364,592 $47.8 Million
Q4 2019

Jan 29, 2020

SELL
$127.5 - $146.44 $942,607 - $1.08 Million
-7,393 Reduced 1.93%
376,022 $54.9 Million
Q3 2019

Oct 28, 2019

SELL
$126.95 - $142.14 $1.55 Million - $1.73 Million
-12,189 Reduced 3.08%
383,415 $49.6 Million
Q2 2019

Jul 25, 2019

BUY
$131.15 - $144.24 $184,921 - $203,378
1,410 Added 0.36%
395,604 $55.1 Million
Q1 2019

Apr 29, 2019

BUY
$125.72 - $139.79 $6.47 Million - $7.2 Million
51,490 Added 15.02%
394,194 $55.1 Million
Q4 2018

Feb 04, 2019

BUY
$122.84 - $147.84 $158,586 - $190,861
1,291 Added 0.38%
342,704 $44.2 Million
Q3 2018

Nov 08, 2018

SELL
$121.58 - $142.88 $1.17 Million - $1.37 Million
-9,598 Reduced 2.73%
341,413 $47.2 Million
Q2 2018

Jul 19, 2018

SELL
$119.4 - $131.76 $24.3 Million - $26.8 Million
-203,406 Reduced 36.69%
351,011 $42.6 Million
Q1 2018

Apr 24, 2018

SELL
$125.1 - $148.14 $5.6 Million - $6.63 Million
-44,786 Reduced 7.47%
554,417 $71 Million
Q4 2017

Feb 12, 2018

SELL
$131.22 - $143.62 $3.16 Million - $3.46 Million
-24,112 Reduced 3.87%
599,203 $83.7 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $80.7 Million - $84.4 Million
623,315
623,315 $81 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Hartford Investment Management CO Portfolio

Follow Hartford Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.